PMC10134185_01
Bilateral necrotic facial rash with involvement of the neck and the clavicle with
underlying erythema.
10.1177_23247096231168114-fig1.jpg
PMC10134185_01_10.1177_23247096231168114-fig1.jpg
fig1-23247096231168114
Six days after starting immunotherapy, the patient presented to the hospital with a new-onset facial rash and associated pain (Figure 1-3).
Planning CT scan showing upper and lip in Axial view. The planning CT images show
contouring which corresponds to different radiation dose levels.. Figure 2. Planning CT scan showing lower lip in Axial view. The planning
CT images show contouring which corresponds to different radiation dose levels.
10.1177_23247096231168114-fig2.jpg
PMC10134185_01_10.1177_23247096231168114-fig2.jpg
fig2-23247096231168114
Six days after starting immunotherapy, the patient presented to the hospital with a new-onset facial rash and associated pain (Figure 1-3).
Dosimetry image showing dose distribution of radiation therapy at 1.2 cm depth
(500-7000 cGy).
10.1177_23247096231168114-fig3.jpg
PMC10134185_01_10.1177_23247096231168114-fig3.jpg
fig3-23247096231168114
Six days after starting immunotherapy, the patient presented to the hospital with a new-onset facial rash and associated pain (Figure 1-3).
Timeline of events from the patient's initial presentation to the hospital to the
development of the bilateral facial rash.
10.1177_23247096231168114-fig4.jpg
PMC10134185_01_10.1177_23247096231168114-fig4.jpg
fig4-23247096231168114
A timeline of our patient's clinical course from initial presentation to diagnosis is shown in Figure 4.